Aktuelle Rheumatologie 2018; 43(03): 231-234
DOI: 10.1055/s-0043-120991
Übersichtsarbeit
Georg Thieme Verlag KG Stuttgart · New York

Die Arthropathie bei hereditärer Hämochromatose

Eine wichtige Differenzialdiagnose zu entzündlichen und degenerativen GelenkerkrankungenArthropathy in Hereditary Haemochromatosis
Gernot Keyßer
1   Department für Innere Medizin, Klinik und Poliklinik für Innere Medizin II, Universitätsklinikum Halle (Saale), Halle (Saale)
› Author Affiliations
Further Information

Publication History

Publication Date:
27 November 2017 (online)

Zusammenfassung

Die Arthropathie bei hereditärer Hämochromatose (HH) ist eine wichtige metabolische und die häufigste genetisch bedingte Gelenkerkrankung in der Rheumatologie. Ihre Manifestation ist variabel. Unbehandelt ist die Erkrankung regelhaft progredient und gibt Anlass zu Verwechslungen mit Arthrosen, rheumatoider Arthritis oder einer Chondrokalzinose aus anderer Ursache. Dank der Identifikation der wesentlichen Risikogene hat sich die Diagnostik der HH in den letzten Jahren so verbessert, dass das Vollbild mit ausgeprägter Schädigung von Leber, Pankreas und Herz seltener geworden ist. Als Therapie hat die Aderlassbehandlung nichts von ihrer Bedeutung verloren. Das Screening von Familienangehörigen Betroffener kann subklinische Fälle erkennen, bevor eine massive Eisenüberladung einsetzt.

Abstract

Hereditary haemochromatosis (HH) arthropathy is an important metabolic and the most frequent inheritable joint disease in rheumatology. The involvement of joints in HH is variable and usually progressive. HH arthropathy may be misclassified as osteoarthritis, rheumatoid arthritis or chondrocalcinosis from other causes. As the most relevant associated gene defects have been identified, diagnostic accuracy has largely improved over the past few years. Therefore, the development of the full-blown picture of HH with marked damage of liver, pancreas and heart has become rare. Treatment continues to rely on phlebotomy. The screening of relatives may identify early cases before excessive iron overload sets in.

 
  • Literatur

  • 1 Feder JN, Gnirke A, Thomas W. et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature genetics 1996; 13: 399-408
  • 2 Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet 2016; 388: 706-716
  • 3 Riehl M. Die hereditäre Hämochromatose: Eine interdisziplinäre diagnostische und therapeutische Herausforderung. Aktuelle Rheumatologie 2017; DOI: 10.1055/s-0042-124370.
  • 4 Fracanzani AL, Piperno A, Valenti L. et al. Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors. Hepatology 2010; 51: 501-510
  • 5 Kew MC. Hepatocellular carcinoma: epidemiology and risk factors. Journal of hepatocellular carcinoma 2014; 1: 115-125
  • 6 Gulati V, Harikrishnan P, Palaniswamy C. et al. Cardiac involvement in hemochromatosis. Cardiology in review 2014; 22: 56-68
  • 7 McDermott JH, Walsh CH. Hypogonadism in hereditary hemochromatosis. The Journal of clinical endocrinology and metabolism 2005; 90: 2451-2455
  • 8 Gan EK, Powell LW, Olynyk JK. Natural history and management of HFE-hemochromatosis. Seminars in liver disease 2011; 31: 293-301
  • 9 Sinigaglia L, Fargion S, Fracanzani AL. et al. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. The Journal of rheumatology 1997; 24: 1809-1813
  • 10 Faraawi R, Harth M, Kertesz A. et al. Arthritis in hemochromatosis. The Journal of rheumatology 1993; 20: 448-452
  • 11 Richardson A, Prideaux A, Kiely P. Haemochromatosis: unexplained metacarpophalangeal or ankle arthropathy should prompt diagnostic tests: findings from two UK observational cohort studies. Scandinavian journal of rheumatology 2017; 46: 69-74
  • 12 Montgomery KD, Williams JR, Sculco TP. et al. Clinical and pathologic findings in hemochromatosis hip arthropathy. Clinical orthopaedics and related research 1998; 179-187
  • 13 Gottschalk R, Neeck G, Wigand R. et al. [Hemochromatosis arthropathy--an early manifestation of genetic hemochromatosis]. Zeitschrift fur Rheumatologie 1997; 56: 156-162
  • 14 Barton JC, Rao SV, Pereira NM. et al. Juvenile hemochromatosis in the southeastern United States: a report of seven cases in two kinships. Blood cells, molecules & diseases 2002; 29: 104-115
  • 15 Guggenbuhl P, Brissot P, Loreal O. Miscellaneous non-inflammatory musculoskeletal conditions. Haemochromatosis: the bone and the joint. Best practice & research Clinical rheumatology 2011; 25: 649-664
  • 16 Huaux JP, Geubel A, Koch MC. et al. The arthritis of hemochromatosis. A review of 25 cases with special reference to chondrocalcinosis, and a comparison with patients with primary hyperparathyroidism and controls. Clinical rheumatology 1986; 5: 317-324
  • 17 Adams PC, Speechley M. The effect of arthritis on the quality of life in hereditary hemochromatosis. The Journal of rheumatology 1996; 23: 707-710
  • 18 Bacon BR, Adams PC, Kowdley KV. et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 328-343
  • 19 Adams PC, Barton JC, Guo H. et al. Serum ferritin is a biomarker for liver mortality in the Hemochromatosis and Iron Overload Screening Study. Annals of hepatology 2015; 14: 348-353
  • 20 Timsit MA, Bardin T. Metabolic arthropathies. Current opinion in rheumatology 1994; 6: 448-453
  • 21 Oppl B, Zwerina J. [Hemochromatosis]. Zeitschrift fur Rheumatologie 2015; 74: 609-616 quiz 617
  • 22 Nozaki Y, Sato N, Tajima T. et al. Usefulness of magnetic resonance imaging for the diagnosis of hemochromatosis with severe hepatic Steatosis in Nonalcoholic Fatty Liver Disease. Intern Med 2016; 55: 2413-2417
  • 23 Yamashita C, Adams PC. Natural history of the C282Y homozygote for the hemochromatosis gene (HFE) with a normal serum ferritin level. Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association 2003; 1: 388-391
  • 24 Dallos T, Sahinbegovic E, Aigner E. et al. Validation of a radiographic scoring system for haemochromatosis arthropathy. Annals of the rheumatic diseases 2010; 69: 2145-2151
  • 25 Oke AR, Wong E, McCrae F. et al. Hereditary hemochromatosis arthropathy and Doppler ultrasound findings of synovitis. Rheumatology (Oxford) 2017; DOI: 10.1093/rheumatology/kex069.
  • 26 Frenzen K, Schafer C, Keysser G. Erosive and inflammatory joint changes in hereditary hemochromatosis arthropathy detected by low-field magnetic resonance imaging. Rheumatology international 2013; 33: 2061-2067
  • 27 Sundic T, Hervig T, Hannisdal S. et al. Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis. Blood transfusion=Trasfusione del sangue 2014; 12 (Suppl. 01) s84-s89